Compare IKT & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IKT | EVTL |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | 454 |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.1M | 233.3M |
| IPO Year | 2020 | N/A |
| Metric | IKT | EVTL |
|---|---|---|
| Price | $1.70 | $2.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $5.00 | ★ $12.50 |
| AVG Volume (30 Days) | 1.2M | ★ 3.3M |
| Earning Date | 03-26-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $1.90 |
| 52 Week High | $2.37 | $7.60 |
| Indicator | IKT | EVTL |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 36.54 |
| Support Level | $1.43 | $1.90 |
| Resistance Level | $1.74 | $4.80 |
| Average True Range (ATR) | 0.11 | 0.32 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 59.62 | 33.23 |
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.